You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma

 

Online download statistics by month:

Online download statistics by month: August 2023 to January 2026

AbstractFullPdf
Aug 202341041193
Sep 202311511539
Oct 2023878748
Nov 2023787830
Dec 2023838445
Jan 2024545427
Feb 2024474727
Mar 2024656560
Apr 2024424240
May 2024484936
Jun 2024515334
Jul 2024676844
Aug 2024424121
Sep 2024383825
Oct 20243737142
Nov 2024242517
Dec 2024959619
Jan 2025272719
Feb 2025949420
Mar 2025616126
Apr 2025373712
May 2025414125
Jun 2025252617
Jul 2025110
Jan 2026110
Total16701678866